COMPANY

Sudo Biosciences

HQ: Carmel, IN source · sudobio.com ↗ · Midwest

Keywords: neurology immunology

Location: Carmel, IN · source · Oct 15, 2026

Profile checked Oct 10, 2026

Raises and deals from press releases

Raise Series B (second close) · $30M · announced Feb 13, 2024 Company release ↗
Source quote
- Feb 13, 2024 · Company release ↗
  “today announced that during January 2024, it completed a second close of its Series B financing, raising an additional $30 million”
Raise Series B · $116M · announced Dec 20, 2023 Company release ↗
Source quote
- Dec 20, 2023 · Company release ↗
  “CARMEL, IN – December 20, 2023: Sudo Biosciences (“Sudo”), a biopharmaceutical company committed to designing and developing best-in-class precision TYK2 (tyrosine kinase 2) inhibitors, today announced the close of a $116 million Series B financing round co-led by Enavate Sciences and TPG, which”

Raises announced in these releases: $147M disclosed (round total as stated in the release).

From the company’s own releases; this list is partial. All raises and deals